GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SCL Science Inc (XKRX:246960) » Definitions » Capital Expenditure

SCL Science (XKRX:246960) Capital Expenditure : ₩-3,243.36 Mil (TTM As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is SCL Science Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

SCL Science's cash flow for capital expenditures for the three months ended in Mar. 2024 was ₩-427 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-3,243.36 Mil.

SCL Science Capital Expenditure Historical Data

The historical data trend for SCL Science's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SCL Science Capital Expenditure Chart

SCL Science Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -289.38 -1,820.08 -6,342.82 -890.29 -2,898.71

SCL Science Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -82.20 -230.63 -244.72 -2,341.17 -426.85

SCL Science Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-3,243.36 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SCL Science (XKRX:246960) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SCL Science Inc (XKRX:246960) » Definitions » Capital Expenditure
Comparable Companies
XKRX:419540 XKRX:238120 XKRX:058110 XKRX:115480 XKRX:200580 XKRX:335810 XKRX:402420 XKRX:311960 XKRX:043100 XKRX:337840 ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
N/A
Address
Seonyu-ro 13-gil, ACE Hitech City 2, 25, Number 1209, Yeongdeungpo-gu, Seoul, KOR, 07282
Website
http://www.innotherapy.com
InnoTherapy Inc is a South-Korea based medical device company. It has developed a technology to control physical property of bio-inspired by the adhesive properties of living organisms. The products offered by the company include InnoSEAL, EndoSil and GellySil among others.

SCL Science (XKRX:246960) Headlines

No Headlines